To access this element change to forms mode OFF
Grant Award View - GA29928
Exploiting metabolic vulnerabilities in the detection and treatment of...
GA ID:
GA29928
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$650,818.42
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Exploiting metabolic vulnerabilities in the detection and treatment of lung cancer
Purpose:
Lung cancer is a leading cause of cancer-related death in Australia, with new treatment options and early detection a research priority. The proposed project aims to identify lung cancer by-products that can be detected in the patient’s blood, together with the identification of specific therapies tailored to the patient. This will result in a novel combination of lung cancer detection and personalised therapy that will advance current clinical practice through the initiation of clinical trials.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1159002
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA